Built for investing
Run Analyses Faster and More Thoroughly

Continuously scan the flow of presentations, transcripts, press releases for the stock moving tidbits specific to your universe. Query all the relevant documents, verify findings, and build stronger analyses. Deploy your complex process at scale — Powered by AI and always rooted in historical price and fundamental Data. Obi's starting industry of focus is Biotech.

Core features

  • Real-time Feed

    A real-time monitor of new primary documents from your watchlists. Differently from other feeds, when a document is published, it will be automatically analysed to highlight just the information items that matter for that stock.

  • Run queries or analyses

    How did ANAB's commentary on the Ph2 AD trial's efficacy & safety change over time?

    What readouts are expected for 1Q25 for small caps in my watchlist? Which ones were originally planned for earlier/later in the year?

    How many days does Eli Lilly usually wait between the trial "completion" and the topline data press release?

  • Fast, exhaustive and rooted in history

    Deliver key insights within minutes (not hours) by quickly identifying critical information and pivots in commentary across any number of documents in virtually no time.

    Historical price reaction and historical databases of previous developments are key to deliver fast and accurate insights.

  • Analysis Automation

    Our proprietary automation suite lets you save your workflows and analyses and run them at scale whenever your triggers are met, in plain finance lingo (eg, "when a new 8-K is out", "when a stock moves +/- X standard deviations", "when new Ph3 data in CSCC is out").

Enough with the menial work. Focus on the reasons why

Obi runs automatic analyses when new info is available, such as new filings, calls, slides, industry sources, and it shows you what matters, as it happens.

So you can focus on the reasons why something happens, instead of skimming information.

Featured image

FAQs

Have a question about our AI powered anaysis companion? Some preliminary answers below, but we'd be happy to chat through the details.